Kaprishi Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
About Kaprishi Pharma
Kaprishi Pharma Private Limited (KPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 29 June 2018 (Six years and seven months 25 days old ). Its registered office is in Kamrup, Assam, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 Cr.
Simanta Barman and Pritikongkana Barman serve as directors at the Company.
Company Details
- Location
Kamrup, Assam, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52602AS2018PTC018600
- Company No.
018600
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
What products or services does Kaprishi Pharma Private Limited offer?
Kaprishi Pharma Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Respiratory Therapy Equipment, Face Mask & Medical PPE Kits, Face Mask, Cosmetics, Hair & Beauty Products, Body Masks, N95 Mask, Venus N95 Mask, Antibiotic Injection, Meropenem Injection.
Who are the key members and board of directors at Kaprishi Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Simanta Barman  | Director | 29-Jun-2018 | Current |
| Pritikongkana Barman | Director | 29-Jun-2018 | Current |
Financial Performance of Kaprishi Pharma.
Kaprishi Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Kaprishi Pharma?
Unlock access to Kaprishi Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Assam State Film (Finance & Development )Corporation LtdSimanta Barman is a mutual person
- Guwahati Mobisoft Private Limited
Simanta Barman is a mutual person
- Zeebon Technologies Private Limited
Simanta Barman is a mutual person
Charges (Loans)
₹20.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.60 Cr
- Others : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2023 | State Bank Of India | ₹1.60 Cr | Open |
| 07 Oct 2023 | Others | ₹4.00 M | Open |
How Many Employees Work at Kaprishi Pharma?
Unlock and access historical data on people associated with Kaprishi Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kaprishi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaprishi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.